Bionexus Gene Lab Share Price Today
(NASDAQ: BGLC)

Name: Bionexus Gene Lab Share Price Today (NASDAQ: BGLC) - Bionexus Gene Lab Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Bionexus Gene Lab share price is $0.34 & ₹29.57 as on 6 Mar 2025, 2.30 'hrs' IST

$0.34

▲

0.01

(4.37%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Bionexus Gene Lab share price in Dollar and Rupees. Guide to invest in Bionexus Gene Lab stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bionexus Gene Lab, along with analyst recommendations, forecasts, and comprehensive financials.

Bionexus Gene Lab share price movements

Today's Low: $0.32
Today's High: $0.37
$0.34
6.85%
Downside
Day's Volatility :14.15%
Upside
7.83%
52 Weeks Low: $0.21
52 Weeks High: $1.07
$0.34
38.09%
Downside
52 Weeks Volatility :80.33%
Upside
68.22%

Bionexus Gene Lab (BGLC) Returns

Period	Bionexus Gene Lab Corp	Index (Russel 2000)
3 Months	9.1%	0.0%
6 Months	-22.46%	0.0%
1 Year	-60.1%	0.0%
3 Years	-98.45%	-11.6%

Bionexus Gene Lab (BGLC) Key Statistics

in dollars & INR

Previous Close	$0.3273
Open	$0.3275
Today's High	$0.3689
Today's Low	$0.3167
Market Capitalization	$5.9M
Today's Volume	$301.0
52 Week High	$1.07
52 Week Low	$0.2105
Revenue TTM	$9.3M
EBITDA	$-317.3K
Earnings Per Share (EPS)	$-0.06
Profit Margin	-10.17%
Quarterly Earnings Growth YOY	-0.95%
Return On Equity TTM	-9.87%

How to invest in Bionexus Gene Lab Stock (BGLC) from India?

It is very easy for Indian residents to invest directly in Bionexus Gene Lab from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bionexus Gene Lab stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bionexus Gene Lab or BGLC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bionexus Gene Lab or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bionexus Gene Lab shares which would translate to 2.558 fractional shares of Bionexus Gene Lab as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bionexus Gene Lab, in just a few clicks!

Returns in Bionexus Gene Lab (BGLC) for Indian investors in Rupees

The Bionexus Gene Lab stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Bionexus Gene Lab investment value today

Current value as on today

₹46,426

Returns

₹53,574

(-53.57%)

Returns from Bionexus Gene Lab Stock

₹58,537 (-58.54%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Bionexus Gene Lab (BGLC)

-50%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Bionexus Gene Lab Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Bionexus Gene Lab

Insights on Bionexus Gene Lab Stock (Ticker Symbol: BGLC)

Price Movement
In the last 3 years, BGLC stock has moved down by -98.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 1.97M → 2.63M (in $), with an average increase of 24.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 199.10K → -1.34M (in $), with an average decrease of 775.7% per quarter
BGLC vs APD (1 yr)
In the last 1 year, Air Products & Chemicals Inc. has given 27.5% return, outperforming this stock by 89.1%
BGLC vs LIN (3 yr)
In the last 3 years, Linde Plc has given 33.7% return, outperforming this stock by 132.2%
Price to Sales
ForBGLC every $1 of sales, investors are willing to pay $0.6, whereas for Air Products & Chemicals Inc., the investors are paying $5.6 for every $1 of sales.

BGLC Bionexus Gene Lab Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$212.3K	-
Net Income	$26.5K	-
Net Profit Margin	12.46%	-

	FY19	Y/Y Change
Revenue	$127.0K	↓ 40.21%
Net Income	$-246.5K	↓ 1031.69%
Net Profit Margin	-194.14%	↓ 206.6%

	FY20	Y/Y Change
Revenue	$11.4M	↑ 8872.03%
Net Income	$1.1M	↓ 543.91%
Net Profit Margin	9.61%	↑ 203.75%

	FY21	Y/Y Change
Revenue	$13.4M	↑ 17.31%
Net Income	$751.6K	↓ 31.31%
Net Profit Margin	5.62%	↓ 3.99%

	FY22	Y/Y Change
Revenue	$10.9M	↓ 18.21%
Net Income	$-356.0K	↓ 147.36%
Net Profit Margin	-3.26%	↓ 8.88%

	FY23	Y/Y Change
Revenue	$9.8M	↓ 10.6%
Net Income	$-2.6M	↑ 638.57%
Net Profit Margin	-26.91%	↓ 23.65%

	Q2 FY23	Q/Q Change
Revenue	$2.6M	↑ 7.98%
Net Income	$-259.3K	↑ 275.37%
Net Profit Margin	-10.1%	↓ 7.19%

	Q3 FY23	Q/Q Change
Revenue	$2.6M	↓ 0.51%
Net Income	$-2.6M	↑ 906.03%
Net Profit Margin	-102.13%	↓ 92.03%

	Q4 FY23	Q/Q Change
Revenue	$2.3M	↓ 10.99%
Net Income	$307.4K	↓ 111.79%
Net Profit Margin	13.52%	↑ 115.65%

	Q1 FY24	Q/Q Change
Revenue	$2.4M	↑ 4.79%
Net Income	$-103.8K	↓ 133.75%
Net Profit Margin	-4.36%	↓ 17.88%

	Q2 FY24	Q/Q Change
Revenue	$2.0M	↓ 17.1%
Net Income	$199.1K	↓ 291.89%
Net Profit Margin	10.08%	↑ 14.44%

	Q3 FY24	Q/Q Change
Revenue	$2.6M	↑ 33.21%
Net Income	$-1.3M	↓ 775.71%
Net Profit Margin	-51.15%	↓ 61.23%

	FY18	Y/Y Change
Profit	$28.8K	-

	FY19	Y/Y Change
Profit	$55.9K	↑ 94.29%

	FY20	Y/Y Change
Profit	$1.7M	↑ 2977.27%

	FY21	Y/Y Change
Profit	$2.2M	↑ 27.56%

	FY22	Y/Y Change
Profit	$1.3M	↓ 42.61%

	FY23	Y/Y Change
Profit	$1.3M	↑ 5.6%

	Q2 FY23	Q/Q Change
Profit	$339.7K	↓ 7.91%

	Q3 FY23	Q/Q Change
Profit	$354.3K	↑ 4.3%

	Q4 FY23	Q/Q Change
Profit	$266.6K	↓ 24.77%

	Q1 FY24	Q/Q Change
Profit	$344.9K	↑ 29.39%

	Q2 FY24	Q/Q Change
Profit	$288.7K	↓ 16.29%

	Q3 FY24	Q/Q Change
Profit	$326.5K	↑ 13.1%

	FY18	Y/Y Change
Operating Cash Flow	$-274.1K	↓ 176.73%
Investing Cash Flow	$-51.7K	↓ 99.03%
Financing Cash Flow	$742.9K	↓ 87.15%

	FY19	Y/Y Change
Operating Cash Flow	$-217.3K	↓ 20.73%
Investing Cash Flow	$-12.8K	↓ 75.21%
Financing Cash Flow	$-180.8K	↓ 124.34%

	FY20	Y/Y Change
Operating Cash Flow	$552.7K	↓ 354.37%
Investing Cash Flow	$1.3M	↓ 10398.74%
Financing Cash Flow	$-4.9K	↓ 97.26%

	FY21	Y/Y Change
Operating Cash Flow	$9.2K	↓ 98.34%
Investing Cash Flow	$-490.6K	↓ 137.16%
Financing Cash Flow	$-28.2K	↑ 470.49%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-22.0K	↓ 81.37%
Investing Cash Flow	$-3.1K	↓ 39.52%
Financing Cash Flow	$-4.2K	↓ 51.54%

Bionexus Gene Lab Technicals Summary

Sell

Neutral

Buy

Bionexus Gene Lab is currently in a neutral trading position according to technical analysis indicators.

Bionexus Gene Lab (BGLC) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bionexus Gene Lab Corp	-18.58%	-22.46%	-60.1%	-98.45%	-98.66%
Dupont De Nemours Inc	0.9%	-4.53%	10.54%	12.48%	121.02%
Air Products & Chemicals Inc.	-9.03%	11.62%	25.61%	37.86%	48.84%
Sherwin-williams Company, The	-0.65%	-1.33%	5.58%	46.24%	102.19%
Linde Plc	1.44%	-0.9%	-0.49%	70.25%	166.48%
Ecolab Inc.	7.61%	8.54%	19.79%	68.91%	45.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bionexus Gene Lab Corp	NA	NA	NA	0.0	-0.1	-0.02	NA	0.52
Dupont De Nemours Inc	44.54	44.54	0.44	4.38	0.03	0.03	0.02	55.86
Air Products & Chemicals Inc.	17.68	17.68	9.3	12.69	0.22	0.05	0.02	75.03
Sherwin-williams Company, The	33.85	33.85	4.05	12.03	0.69	0.1	0.01	16.21
Linde Plc	33.89	33.89	2.53	16.52	0.17	0.07	0.01	80.49
Ecolab Inc.	36.61	36.61	2.42	7.53	0.25	0.08	0.01	23.46

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bionexus Gene Lab Corp	NA	$5.9M	-98.66%	NA	-10.17%
Dupont De Nemours Inc	Buy	$33.0B	121.02%	44.54	5.68%
Air Products & Chemicals Inc.	Buy	$67.9B	48.84%	17.68	31.88%
Sherwin-williams Company, The	Buy	$89.7B	102.19%	33.85	11.61%
Linde Plc	Buy	$218.6B	166.48%	33.89	19.89%
Ecolab Inc.	Hold	$76.4B	45.65%	36.61	13.42%

About Bionexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Organization	Bionexus Gene Lab
Employees	30
CEO	Mr. Su-Leng Tan
Industry	Commercial Services

Management People of Bionexus Gene Lab

Name	Title
Mr. Su-Leng Tan	CEO, Acting CFO, Secretary & Director
Mr. Kwan Wah Chan	Marketing Manager
Mr. Too Kam Tham	Managing Director

Important FAQs about investing in BGLC Stock from India :

What is Bionexus Gene Lab share price today?

Bionexus Gene Lab share price today stands at $0.34, Open: $0.33 ; Previous Close: $0.33 ; High: $0.37 ; Low: $0.32 ; 52 Week High: $1.07 ; 52 Week Low: $0.21.

The stock opens at $0.33, after a previous close of $0.33. The stock reached a daily high of $0.37 and a low of $0.32, with a 52-week high of $1.07 and a 52-week low of $0.21.

Can Indians buy Bionexus Gene Lab shares?

Yes, Indians can invest in the Bionexus Gene Lab (BGLC) from India.

With INDmoney, you can buy Bionexus Gene Lab at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bionexus Gene Lab at zero transaction cost.

How can I buy Bionexus Gene Lab shares from India?

It is very easy to buy Bionexus Gene Lab from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bionexus Gene Lab (BGLC) be purchased?

Yes, you can buy fractional shares of Bionexus Gene Lab with INDmoney app.

What are the documents required to start investing in Bionexus Gene Lab stocks?

To start investing in Bionexus Gene Lab, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.